Your session is about to expire
← Back to Search
Behavioral Intervention
Communication Campaign for COVID-19 Vaccine Uptake
N/A
Waitlist Available
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will study if using information from wastewater surveillance of COVID-19 can help increase COVID-19 vaccine uptake in New York counties. The study will compare vaccination rates in counties that receive communication campaigns based
Who is the study for?
This trial is for residents of selected rural and urban counties in New York. It aims to understand if local COVID-19 data shared through a communication campaign can encourage more people to get vaccinated.
What is being tested?
The study tests a communications campaign using local wastewater surveillance data on COVID-19 to see if it boosts vaccine uptake. Forty counties are split into two groups, with one receiving the campaign and the other not, to compare results.
What are the potential side effects?
Since this trial involves a communication campaign rather than medical treatment, there are no direct side effects like those associated with drugs or vaccines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 11 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
COVID-19 Vaccine Uptake
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Communications Intervention GroupExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Syracuse UniversityLead Sponsor
51 Previous Clinical Trials
118,012 Total Patients Enrolled